Aprea Therapeutics, Inc. (APRE) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $15.5K | -83.4% |
| 2023 | $93.1K | — |
| 2020 | $25.7K | -16.8% |
| 2019 | $30.9K | +734.7% |
| 2018 | $3.7K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $15.5K | -83.4% |
| 2023 | $93.1K | — |
| 2020 | $25.7K | -16.8% |
| 2019 | $30.9K | +734.7% |
| 2018 | $3.7K | — |